Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Schoemaker Kathleen K
Relationship:   10% Owner
City:   Princeton
State:   NJ
   
Insider Summary:
  
   
Companies Owned :   24    
Direct Shares   8,715,548    

Indirect Shares

   3,038,103      
Direct Value   $228,247,061    

Indirect Value

   $11,224,701      
Total Shares   11,753,651      
Total Value   $239,471,762      


Volcano Corp $0 Cadence Pharmaceuticals Inc $0 Orexigen Therapeutics, Inc. $48 Alimera Sciences Inc $1,095,234 Clovis Oncology, Inc. $661 Glaukos Corp $227,151,118 Volcano Corp $0 Cadence Pharmaceuticals Inc $0 Orexigen Therapeutics, Inc. $48 Alimera Sciences Inc $1,095,234 Clovis Oncology, Inc. $661 Glaukos Corp $227,151,118
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Senomyx Inc SNMX 10% Owner 0 2004-06-25 19,603    Premium*  
            Nuvasive Inc NUVA 10% Owner 0 2004-05-18 31,204    Premium*  
            Santarus Inc SNTS 10% Owner 2004-04-06 0 2004-04-06 64,471    Premium*  
            Somaxon Pharmaceuticals, Inc. SOMX 10% Owner 0 2006-12-21 19,379    Premium*  
            Vanda Pharmaceuticals Inc. VNDA 10% Owner 2006-04-18 0 2006-12-12 21,068    Premium*  
            Northstar Neuroscience Inc NSTR 10% Owner 0 2006-05-10 37,586    Premium*  
            Paratek Pharmaceuticals Inc PRTK 10% Owner 0 2009-01-30 67,875    Premium*  
            Volcano Corp VOLC 10% Owner 2008-04-24 29,887 2008-07-16 62,513    Premium*  
            Cadence Pharmaceuticals Inc CADX 10% Owner 2014-02-12 2,972,678 2014-03-19 0    Premium*  
            Orexigen Therapeutics, Inc. OREX 10% Owner 2007-11-27 9,058 2011-12-22 50,643    Premium*  
            Alimera Sciences Inc ALIM 10% Owner 2014-01-16 3,590,931 2011-06-02 40,790    Premium*  
            Achillion Pharmaceuticals Inc ACHN 10% Owner 0 2013-01-18 244,057    Premium*  
            Zogenix, Inc. ZGNX 10% Owner 2010-11-29 0 2011-09-16 169,251    Premium*  
            Clovis Oncology, Inc. CLVS 10% Owner 2013-06-04 44,034 2011-11-21 51,013    Premium*  
            Durata Therapeutics, Inc. DRTX 10% Owner 0 2012-07-24 22,306    Premium*  
            Esperion Therapeutics, Inc. ESPR 10% Owner 0 2013-07-01 35,253    Premium*  
            Ocera Therapeutics Inc OCRX 10% Owner 2013-07-15 0 2013-07-15 1,920,730    Premium*  
            Tobira Therapeutics Inc TBRA 10% Owner 0 2013-08-27 32,091    Premium*  
            Evoke Pharma Inc EVOK 10% Owner 0 2013-09-30 24,256    Premium*  
            Veracyte, Inc. VCYT 10% Owner 2013-11-04 0 2013-11-04 22,730    Premium*  
            Tandem Diabetes Care Inc TNDM 10% Owner 2013-11-19 0 2013-11-19 54,390    Premium*  
            Dicerna Pharmaceuticals Inc DRNA 10% Owner 2014-02-04 0 2014-02-04 13,004    Premium*  
            Achaogen Inc AKAO 10% Owner 2014-03-17 0 2014-03-17 33,890    Premium*  
            Glaukos Corp GKOS 10% Owner 2015-06-30 2,068,960 2015-06-30 0    Premium*  
* Premium Members only  

Records found :    282         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 11 of 12
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
TBRA Tobira Therapeutics Inc 10% Owner   –       –       •   2013-08-21 3 IO $0.00 $0 I/I 0 53,099 -
EVOK Evoke Pharma Inc 10% Owner   –       –       •   2013-09-24 3 IO $0.00 $0 I/I 0 5,250 -
NUVA Nuvasive Inc 10% Owner   –       –       •   2004-05-18 4 OE $0.63 $83,636 I/I 133,818 1,751,616 -
CADX Cadence Pharmaceuticals I... 10% Owner   –       –       •   2014-02-12 4 OE $7.84 $182,805 D/D 23,317 63,801 0 -
CADX Cadence Pharmaceuticals I... 10% Owner   –       –       •   2014-02-12 4 OE $7.84 $10,717,437 D/D 1,367,020 3,738,210 0 -
GKOS Glaukos Corp 10% Owner   –       –       •   2015-06-30 4 OE $7.65 $156,596 D/D 20,470 2,077,660 0 -
SOMX Somaxon Pharmaceuticals, ... 10% Owner   –       –       •   2006-09-18 4 S $13.03 $84,161 I/I (6,459) 25,838 0 -
VOLC Volcano Corp 10% Owner   –       –       •   2006-12-06 4/A S $16.75 $25,263,154 I/I (1,508,248) 112,200 0 -
VOLC Volcano Corp 10% Owner   –       –       •   2006-12-06 4 S $16.75 $25,263,171 I/I (1,508,249) 112,200 0 -
VNDA Vanda Pharmaceuticals Inc... 10% Owner   –       –       •   2006-12-12 4 S $25.62 $330,498 I/I (12,900) 21,068 0 -
SOMX Somaxon Pharmaceuticals, ... 10% Owner   –       –       •   2006-12-21 4 S $13.52 $87,326 I/I (6,459) 19,379 0 -
VOLC Volcano Corp 10% Owner   –       –       •   2007-05-18 4 S $19.25 $486,005 I/I (25,247) 91,781 0 -
PRTK Paratek Pharmaceuticals I... 10% Owner   –       –       •   2007-06-06 4 S $11.26 $275,870 I/I (24,500) 73,575 0 -
OREX Orexigen Therapeutics, In... 10% Owner   –       –       •   2007-11-27 4 S $14.27 $299,670 I/I (21,000) 83,975 0 -
VOLC Volcano Corp 10% Owner   –       –       •   2008-04-08 4 S $12.98 $218,479 I/I (16,832) 78,168 0 -
VOLC Volcano Corp 10% Owner   –       –       •   2008-07-16 4 S $14.49 $280,483 I/I (19,357) 62,513 0 -
PRTK Paratek Pharmaceuticals I... 10% Owner   –       –       •   2009-01-28 4 S $0.93 $34,131 I/I (36,700) 72,738 0 -
PRTK Paratek Pharmaceuticals I... 10% Owner   –       –       •   2009-01-29 4 S $0.91 $57,330 I/I (63,000) 71,302 0 -
PRTK Paratek Pharmaceuticals I... 10% Owner   –       –       •   2009-01-30 4 S $0.98 $147,294 I/I (150,300) 67,875 0 -
ALIM Alimera Sciences Inc 10% Owner   –       –       •   2011-06-02 4 S $8.04 $55,589 I/I (6,914) 40,790 0 -
CLVS Clovis Oncology, Inc. 10% Owner   –       –       •   2013-03-04 4 S $24.44 $605,697 D/D (24,783) 2,966,154 0 -
CLVS Clovis Oncology, Inc. 10% Owner   –       –       •   2013-03-04 4 S $24.44 $10,191 D/D (417) 50,596 0 -
CLVS Clovis Oncology, Inc. 10% Owner   –       –       •   2013-03-05 4 S $24.69 $52,639 D/D (2,132) 48,464 0 -
CLVS Clovis Oncology, Inc. 10% Owner   –       –       •   2013-03-05 4 S $24.69 $3,132,371 D/D (126,868) 2,839,286 0 -
CLVS Clovis Oncology, Inc. 10% Owner   –       –       •   2013-03-06 4 S $24.51 $2,410,534 D/D (98,349) 2,740,937 0 -
  282  Records found
  1   2   3   4   5   6   7   8   9   10   11  12      
  Page 11 of 12  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us